Large accountable care organizations committed to overhauled Medicare program
Dropout rates for the program remain relatively low among ACOs, researchers found.
ACC 2019: 12-month results show ticagrelor safe in STEMI patients treated with thrombolysis
When comparing ischemic endpoints, no significant difference was found between patients who received ticagrelor and patients who received clopidogrel.
ACC 2019: Use of guideline-directed medical therapies for comorbidities may improve outcomes for patients with atrial fibrillation
Although nearly two-thirds of the study population did not receive all the guideline-directed medical therapies for which they were eligible, use of all therapies was linked to better outcomes in s
ACC 2019: Some heart disease, AF patients on combined therapies could skip aspirin
Data show bleeding risk from aspirin could outweigh protection from another heart event.
ACC 2019: Study confirms diagnostic accuracy of non-invasive technology for heart pain
Patients with negative FFR-CT scans had a low, one-year risk of a heart attack or death.
Compound improves heart failure biomarker even after hospitalization
A new study shows sacubitril/valsartan can still improve heart stress if prescribed later.
ACC 2019: A multidisciplinary approach to improve care for geriatric heart failure patients
Care for older adults with heart failure can be optimized using a four-domain framework including medical, mind, physical function, and social environment.
ACC 2019: Disparities persist in treatment of symptomatic aortic valve stenosis
New research shows that although racial disparities have diminished in recent years, gender disparities are still common.
ACC 2019: Oral anticoagulants underused, aspirin overused to treat atrial fibrillation in patients with advanced chronic kidney disease
Only approximately half of patients with chronic kidney disease and atrial fibrillation were treated with oral anticoagulants (OACs), and this proportion decreased significantly as kidney disease became more severe.
ACC 2019: Benefits and drawbacks of high-sensitivity troponin use in low-risk patients with chest pain
High-sensitivity troponin, an assay that is relatively new in the U.S., allows providers to assess low-risk chest pain patients more quickly and determine whether they have had a heart attack or myocardial infarction.